Competitive Sports Participation in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center's Early Experience
- PMID: 29766881
- DOI: 10.1016/j.jacep.2016.01.020
Competitive Sports Participation in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia: A Single Center's Early Experience
Abstract
Objectives: The study sought to determine the outcomes of continued sports participation in patients with catecholaminergic polymorphic ventricular tachycardia (CPVT).
Background: Patients with CPVT are at increased risk of sudden death with exertion. Currently, CPVT patients are advised disqualification from nearly all sports in accordance with expert opinion guidelines. However, we have approached this complex issue with a shared decision making model respecting a patient's and their family's right to be a competitive athlete following institution of comprehensive CPVT-directed treatment program.
Methods: A retrospective record review was performed on patients with CPVT who were >6 years of age at the time of initial evaluation to determine their athlete status and frequency/scope of subsequent CPVT-triggered events.
Results: Among 63 eligible patients with CPVT (34 females, mean age at diagnosis 16.6 ± 12.9 years), 31 (49%) were athletes at some point in their life. Compared to the nonathletes, these athletes were significantly younger at diagnosis (11.8 ± 6.6 years vs. 21.3 ± 15.6 years; p = 0.003) and more symptomatic (21 [68%] vs. 13 [41%]; p = 0.04). Following diagnosis, 21 of 24 athletes (88%) continued competition. For these 21 athletes, 16 (76%) had experienced 32 CPVT-triggered events prior to diagnosis versus 57 events in 18 nonathletes (43%; p = 0.02). During follow-up, 3 events occurred in 3 of 21 athletes (14%) compared to 7 events in 6 of 42 nonathletes (14%, p = 1.00). No event resulted in death, and all received an adjustment in their CPVT therapy.
Conclusions: Although sports participation is a risk taking behavior in undiagnosed and untreated CPVT, the risk may be acceptable for a well-treated and well-informed athlete following the diagnosis of CPVT.
Keywords: CPVT; LCSD; athletes; catecholeminergic polymorphic ventricular tachycardia; left cardiac sympathetic denervation; sports; sudden death.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Case Report: The unrelenting journey-successful resolution of catecholaminergic polymorphic ventricular tachycardia (CPVT) through right cardiac sympathetic denervation in a teenager after left cardiac sympathetic denervation.Front Cardiovasc Med. 2024 Dec 13;11:1477359. doi: 10.3389/fcvm.2024.1477359. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39735866 Free PMC article.
-
Sudden cardiac arrest during sex in patients with either catecholaminergic polymorphic ventricular tachycardia or long-QT syndrome: a rare but shocking experience.J Cardiovasc Electrophysiol. 2015 Mar;26(3):300-4. doi: 10.1111/jce.12600. Epub 2015 Jan 15. J Cardiovasc Electrophysiol. 2015. PMID: 25514987
-
Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.Heart Rhythm. 2014 Jan;11(1):58-66. doi: 10.1016/j.hrthm.2013.10.027. Epub 2013 Oct 11. Heart Rhythm. 2014. PMID: 24120999
-
Current topics in catecholaminergic polymorphic ventricular tachycardia.J Arrhythm. 2016 Oct;32(5):344-351. doi: 10.1016/j.joa.2015.09.008. Epub 2015 Nov 24. J Arrhythm. 2016. PMID: 27761157 Free PMC article. Review.
-
Left cardiac sympathetic denervation in the management of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: A meta-regression.Congenit Heart Dis. 2019 Nov;14(6):1102-1112. doi: 10.1111/chd.12855. Epub 2019 Oct 16. Congenit Heart Dis. 2019. PMID: 31621201
Cited by
-
Video game ventricular tachycardia: The "Fortnite" phenomenon.HeartRhythm Case Rep. 2020 May 5;6(6):313-317. doi: 10.1016/j.hrcr.2020.02.007. eCollection 2020 Jun. HeartRhythm Case Rep. 2020. PMID: 32577384 Free PMC article. No abstract available.
-
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug. J Arrhythm. 2024. PMID: 39139890 Free PMC article. No abstract available.
-
Rationale and Design of the ORCCA (Outcomes Registry for Cardiac Conditions in Athletes) Study.J Am Heart Assoc. 2023 Jun 6;12(11):e029052. doi: 10.1161/JAHA.122.029052. Epub 2023 Jun 1. J Am Heart Assoc. 2023. PMID: 37259981 Free PMC article.
-
Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology.J Am Coll Cardiol. 2025 Mar 18;85(10):1059-1108. doi: 10.1016/j.jacc.2024.12.025. Epub 2025 Feb 20. J Am Coll Cardiol. 2025. PMID: 39976316 Free PMC article.
-
A Recurrent Exertional Syncope and Sudden Cardiac Arrest in a Young Athlete with Known Pathogenic p.Arg420Gln Variant in the RYR2 Gene.Diagnostics (Basel). 2020 Jun 27;10(7):435. doi: 10.3390/diagnostics10070435. Diagnostics (Basel). 2020. PMID: 32605058 Free PMC article.
LinkOut - more resources
Full Text Sources
Other Literature Sources